BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,810,633 | -29.0% | 204,214 | -18.3% | 0.86% | -33.3% |
| Q4 2022 | $5,370,000 | +4652.2% | 250,000 | +4505.7% | 1.30% | +8540.0% |
| Q1 2022 | $113,000 | +8.7% | 5,428 | +5.1% | 0.02% | 0.0% |
| Q4 2021 | $104,000 | -98.4% | 5,167 | -96.7% | 0.02% | -93.4% |
| Q1 2021 | $6,700,000 | -3.3% | 155,232 | +3.5% | 0.23% | -26.1% |
| Q4 2020 | $6,930,000 | +4.7% | 150,000 | -1.8% | 0.31% | -36.1% |
| Q3 2020 | $6,621,000 | -70.1% | 152,714 | -63.4% | 0.48% | -72.8% |
| Q2 2020 | $22,138,000 | +24.3% | 417,618 | -47.6% | 1.76% | +31.5% |
| Q1 2020 | $17,814,000 | +669.8% | 797,016 | +403.3% | 1.34% | +257.3% |
| Q4 2019 | $2,314,000 | – | 158,373 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |